Jens Hennecke

PhD (Representative of PPF Group)

Jens Hennecke is Chief Business Officer of SOTIO a.s. since March 2015. He is responsible for business strategy as well as for licensing, M&A and investments at Sotio, and as such, for PPF Group’s investment and partnering activities in the biotechnology sector. Jens is a molecular biologist by training and has more than 15 years of business and deal-making track record in the biopharmaceutical industry. Before joining SOTIO, he had his own business consulting firm and has been serving as an advisor for business and corporate development for various European biotech companies. Until 2012, Jens was Senior Vice President for Business Development and a member of the executive management team of Nasdaq-listed Micromet, Inc.. At Micromet, he was responsible for business development, alliance management, intellectual property and other operational functions. During his 12 years tenure at Micromet, Jens closed corporate deals and managed the alliances with multiple large pharma companies on Micromet’s T cell engager BiTE platform and products, and has been instrumental in the $1.2 billion acquisition of Micromet by Amgen in 2012. He received a diploma in biology from the University of Göttingen and completed his Ph.D. thesis at the ETH Zurich. He also carried out post-doctoral research at Harvard University. Jens currently also serves on the supervisory board of Cytune Pharma.